Chemoinformaics analysis of methyl 9,12,15-octadecatrienoate
| Molecular Weight | 292.463 | nRot | 13 |
| Heavy Atom Molecular Weight | 260.207 | nRig | 4 |
| Exact Molecular Weight | 292.24 | nRing | 0 |
| Solubility: LogS | -5.592 | nHRing | 0 |
| Solubility: LogP | 5.718 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 54.6714 |
| nHD | 0 | BPOL | 34.7066 |
| QED | 0.245 |
| Synth | 2.595 |
| Natural Product Likeliness | 1.193 |
| NR-PPAR-gamma | 0.057 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.013 |
| Pgp-sub | 0.001 |
| HIA | 0.083 |
| CACO-2 | -4.832 |
| MDCK | 0.0000407 |
| BBB | 0.019 |
| PPB | 1.00057 |
| VDSS | 1.586 |
| FU | 0.00965122 |
| CYP1A2-inh | 0.893 |
| CYP1A2-sub | 0.259 |
| CYP2c19-inh | 0.666 |
| CYP2c19-sub | 0.062 |
| CYP2c9-inh | 0.674 |
| CYP2c9-sub | 0.98 |
| CYP2d6-inh | 0.681 |
| CYP2d6-sub | 0.778 |
| CYP3a4-inh | 0.849 |
| CYP3a4-sub | 0.09 |
| CL | 3.258 |
| T12 | 0.871 |
| hERG | 0.082 |
| Ames | 0.002 |
| ROA | 0.003 |
| SkinSen | 0.969 |
| Carcinogencity | 0.07 |
| EI | 0.939 |
| Respiratory | 0.418 |
| NR-Aromatase | 0.061 |
| Antiviral | No |
| Prediction | 0.617683 |